Mathai Mammen

Mathai Mammen

Chief Executive Officer at PARABILIS MEDICINES, INC.

Net worth: 511 971 $ as of 31/05/2026

59 year
Health Technology
Finance
Consumer Services

Profile

Mathai Mammen was the founder of Innoviva, Inc., founded in 1996, where the title held was Senior VP-Research & Early Clinical Development from 2011 to 2014.
Dr. Mammen was the founder of Theravance Biopharma, Inc., founded in 1997, where the title held was Senior Vice President-Research & Development from 2014 to 2016.
Current jobs include Chairman, President & Chief Executive Officer at Parabilis Medicines, Inc. since 2023; Director at Kelonia Therapeutics, Inc.; Director at MIT Jameel Clinic; Independent Director at Sandoz Group AG since 2024; Advisor at Foresite Capital Management LLC since 2019; and Senior Advisor at General Atlantic LLC.
Former jobs include Independent Director at 10X Genomics, Inc. from 2017 to 2024; Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2016 to 2017; Global Head-Research & Development at Janssen Research & Development LLC from 2017 to 2022; EVP-Pharmaceuticals, Research & Development at Johnson & Johnson in 2022; Vice President at American Society for Microbiology; and Senior Vice President at Merck & Co., Inc. from 2016 to 2017.
Education includes doctorate degrees from Harvard Medical School, Massachusetts Institute of Technology, and Harvard University, and an undergraduate degree from Dalhousie University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2025 6,098 ( 0% ) 511 971 $ 31/05/2026
10/06/2026 0 ( -.--% ) - $ 31/05/2026

Latest news about Mathai Mammen

Mathai Mammen active positions

CompaniesPositionStart
PARABILIS MEDICINES, INC. Chief Executive Officer 30/06/2023
SANDOZ GROUP AG Director/Board Member 30/04/2024
Consultant / Advisor -
Consultant / Advisor 01/01/2019
MIT Jameel Clinic
Director/Board Member -
Director/Board Member -

Former positions of Mathai Mammen

CompaniesPositionEnd
10X GENOMICS, INC. Director/Board Member 24/10/2024
JOHNSON & JOHNSON Chief Tech/Sci/R&D Officer 08/08/2022
Corporate Officer/Principal 01/01/2022
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Mathai Mammen's experience

Training of Mathai Mammen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

47

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Health Technology

Health Technology

MIT Jameel Clinic

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!